JP2009520502A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520502A5
JP2009520502A5 JP2008547425A JP2008547425A JP2009520502A5 JP 2009520502 A5 JP2009520502 A5 JP 2009520502A5 JP 2008547425 A JP2008547425 A JP 2008547425A JP 2008547425 A JP2008547425 A JP 2008547425A JP 2009520502 A5 JP2009520502 A5 JP 2009520502A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
oligonucleotide
allergen
adjuvant
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008547425A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/048362 external-priority patent/WO2007084237A2/en
Publication of JP2009520502A publication Critical patent/JP2009520502A/ja
Publication of JP2009520502A5 publication Critical patent/JP2009520502A5/ja
Pending legal-status Critical Current

Links

JP2008547425A 2005-12-20 2006-12-19 Cgジヌクレオチド修飾物を含有するトール様受容体の新規な合成アゴニスト Pending JP2009520502A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75233505P 2005-12-20 2005-12-20
US82145806P 2006-08-04 2006-08-04
PCT/US2006/048362 WO2007084237A2 (en) 2005-12-20 2006-12-19 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications

Publications (2)

Publication Number Publication Date
JP2009520502A JP2009520502A (ja) 2009-05-28
JP2009520502A5 true JP2009520502A5 (cg-RX-API-DMAC7.html) 2010-02-18

Family

ID=38288084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547425A Pending JP2009520502A (ja) 2005-12-20 2006-12-19 Cgジヌクレオチド修飾物を含有するトール様受容体の新規な合成アゴニスト

Country Status (7)

Country Link
US (1) US20080279785A1 (cg-RX-API-DMAC7.html)
EP (1) EP1962896A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009520502A (cg-RX-API-DMAC7.html)
AU (1) AU2006336242A1 (cg-RX-API-DMAC7.html)
CA (1) CA2632943A1 (cg-RX-API-DMAC7.html)
MX (1) MX2008008278A (cg-RX-API-DMAC7.html)
WO (1) WO2007084237A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785610B2 (en) 2001-06-21 2010-08-31 Dynavax Technologies Corporation Chimeric immunomodulatory compounds and methods of using the same—III
KR100985457B1 (ko) 2001-06-21 2010-10-06 다이나박스 테크놀로지 코퍼레이션 키메라 면역조절 화합물 및 그것들의 사용 방법
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
US7354907B2 (en) * 2003-02-07 2008-04-08 Idera Pharmaceuticals, Inc. Short immunomodulatory oligonucleotides
CN101820908A (zh) * 2007-10-09 2010-09-01 科利制药公司 包含改性糖部分的免疫刺激寡核苷酸类似物
JP2012516352A (ja) * 2009-01-30 2012-07-19 イデラ ファーマシューティカルズ インコーポレイテッド Tlr9の合成アゴニスト
KR101856462B1 (ko) 2009-03-25 2018-05-10 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물
AR095882A1 (es) 2013-04-22 2015-11-18 Hoffmann La Roche Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2016081911A2 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
JP6121597B1 (ja) * 2016-06-09 2017-04-26 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびTh17細胞分化促進剤
WO2018039629A2 (en) 2016-08-25 2018-03-01 Northwestern University Micellar spherical nucleic acids from thermoresponsive, traceless templates
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)
WO2019066571A2 (ko) 2017-09-28 2019-04-04 연세대학교 산학협력단 골수유래 면역반응 억제세포의 제조방법, 이에 의해 제조된 골수유래 면역반응 억제세포 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149797A (en) * 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
US5652355A (en) * 1992-07-23 1997-07-29 Worcester Foundation For Experimental Biology Hybrid oligonucleotide phosphorothioates
US6346614B1 (en) * 1992-07-23 2002-02-12 Hybridon, Inc. Hybrid oligonucleotide phosphorothioates
TW244371B (cg-RX-API-DMAC7.html) * 1992-07-23 1995-04-01 Tri Clover Inc
US5912332A (en) * 1996-07-26 1999-06-15 Hybridon, Inc. Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
US6589940B1 (en) * 1997-06-06 2003-07-08 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
EP2292632A3 (en) * 2000-09-26 2012-07-25 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
JP4874801B2 (ja) * 2003-06-11 2012-02-15 イデラ ファーマシューティカルズ インコーポレイテッド 安定化免疫調節オリゴヌクレオチド
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment

Similar Documents

Publication Publication Date Title
JP2009521218A5 (ja) 免疫調節オリゴヌクレオチド(imo(tm))の免疫賦活作用
RU2007101039A (ru) Иммуностимулирующие олигонуклеотидные мультимеры
ES2307568T3 (es) Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
ES2600553T3 (es) Ácidos nucleicos inmunoestimuladores
ES2552471T3 (es) Conjugados de agonistas de TLR sintéticos y usos de los mismos
JP6406793B2 (ja) トール様受容体に基づく免疫反応を調整する免疫調節ヌクレオチド(iro)化合物
ES2526879T3 (es) Composiciones y procedimientos para formulaciones de oligonucleótidos
ES2544958T3 (es) Análogos de oligonucleótidos CpG que contienen análogos de T hidrófobos con actividad inmunoestimuladora potenciada
ES2486298T3 (es) Análogos de oligonucleótidos inmunoestimuladores que contienen azúcares modificados
US7427405B2 (en) Immunostimulatory oligonucleotide multimers
JP2009515823A5 (cg-RX-API-DMAC7.html)
WO2006080946A3 (en) Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
JP2001503254A (ja) 免疫刺激ポリヌクレオチド/免疫調節分子複合体
JP2008516634A5 (cg-RX-API-DMAC7.html)
KR20160045726A (ko) 면역조절제로서의 구형 핵산-기재 구축물
JP2007509983A (ja) 免疫刺激力が増強されたc−クラスのオリゴヌクレオチドアナログ
JP2009132737A (ja) 刺激性免疫応答用の核酸組成物
WO2009048945A8 (en) Rapid mucosal gel or film insulin compositions
JP2008531018A5 (cg-RX-API-DMAC7.html)
JP2010532996A5 (cg-RX-API-DMAC7.html)
BRPI0610449A2 (pt) métodos para tratar asma exarcebada por doença infecciosa
ES3035198T3 (en) Cpg amphiphiles and uses thereof
JP2012528867A5 (cg-RX-API-DMAC7.html)
ES2544484T3 (es) Análogos de oligonucleótidos modificados con fosfato con actividad inmunoestimulante
ES2834906T3 (es) Oligonucleótidos de cadena sencilla para la utilización en el tratamiento médico de trastornos de la piel